THE DISTRIBUTION OF IODINE-125 LABELED ALPHA-FETOPROTEIN IN THE ANIMAL ORGANISM AND ITS ACCUMULATION IN THE TUMOR
- Authors: Severin S.E.1, Moskaleva E.Y.1, Kulakov V.N.2, Severin E.S.3, Slobodyanik I.I.2, Klimova T.P.2
-
Affiliations:
- State Health Institution the Moscow Research Institute of Medical Ecology
- Russian Research Center of Molecular Diagnostics and Treatment
- Federal Medical Biophysical A.I. Burnasyan’s Centre of Federal Biomedical Agency of the Russian Federation
- Issue: Vol 67, No 4 (2012)
- Pages: 11-15
- Section: BIOCHEMISTRY: CURRENT ISSUES
- Published: 23.04.2012
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/314
- DOI: https://doi.org/10.15690/vramn.v67i4.193
- ID: 314
Cite item
Full Text
Abstract
The distribution of iodine-125 labeled human alpha-fetoprotein in mice was studied after its intravenous injection. The maximal accumulation of alpha-fetoprotein in different tissues and organs of animals was observed mainly 5 hours after injection. Then the protein was gradually eliminated from the body. In the liver, intestine and blood of intact animals 125I-alpha-fetoprotein persists for at least three days. Accumulation of alpha-fetoprotein in various tissues and organs may determine the different biological effects of this protein. In the mice with transplanted lymphatic leukemia cells P388 the high level of alpha-fetoprotein accumulation was detected in the tumor tissue, reaching 6% of the injected amount per 1 g of tissue. This allows considering the radionuclide-labeled alpha-fetoprotein as a promising medical radionuclide marker for the radiological detection of malignant tumors.
About the authors
S. E. Severin
State Health Institution the Moscow Research Institute of Medical Ecology
Author for correspondence.
Email: sergsev@inbox.ru
доктор химических наук, профессор, член-корр. РАМН, генеральный директор ГУЗ Московский НИИ медицинской экологии Адрес: 117149, Москва, Симферопольский бульвар, д. 8 Тел.: (499) 613-23-20 Россия
E. Yu. Moskaleva
State Health Institution the Moscow Research Institute of Medical Ecology
Email: moskalevaey@mail.ru
доктор биологиче-ских наук, профессор, заведующая лабораторией клеточной биохимии ГУЗ Московский НИИ меди-цинской экологии Департамента здравоохранения г. Москвы Адрес: 117149, Москва, Симферопольский бульвар, д. 8 Тел.: 8-916-522-40-54 Россия
V. N. Kulakov
Russian Research Center of Molecular Diagnostics and Treatment
Email: vikov@rambler.ru
доктор химических наук, профессор, ведущий научный сотрудник отдела радиационных технологий Федеральный медицин-ский биофизический центр им. А.И. Бурназяна Федерального медико-биологического агентства Российской Федерации Адрес: 123182, Москва, ул. Живописная, д. 46 Тел.: 8(499) 193-01-86; факс: 8(499) 193-45-73 Россия
E. S. Severin
Federal Medical Biophysical A.I. Burnasyan’s Centre of Federal Biomedical Agency of the Russian Federation
Email: e.severin@mail.ru
доктор химических наук, профессор, член-корр. РАН, генеральный директор ОАО «Всероссийский научный центр молекулярной диагностики и лечения» Адрес: 117149, Москва, Симферопольский бульвар, д. 8 Тел.: (499) 613-23-51 Россия
I. I. Slobodyanik
Russian Research Center of Molecular Diagnostics and Treatment
Email: vikov@rambler.ru
старший инженер отдела радиационных технологий Федерального медицин-ского биофизического центра им. А.И. Бурназяна Федерального медико-биологического агентства Российской Федерации Адрес: 123182, Москва, ул. Живописная, д. 46 Тел.: 8(499) 193-01-86; факс: 8(499) 193-45-73 Россия
T. P. Klimova
Russian Research Center of Molecular Diagnostics and Treatment
Email: tab@ineos.ac.ru
кандидат физико-математических наук, научный сотрудник Института элементоорганических соединений им. А.Н. Несмеянова РАН Адрес: 119991, Москва, ул. Вавилова, д. 28 Тел.: 8(499) 135-92-69 Россия
References
- Deutsch H.F. Chemistry and biology of alpha-fetoprotein. Adv. Cancer Res. 1991; 56: 253–312.
- Chereshnev V.A., Rodionov S.Yu., Cherkasov V.A., Malyutina N.N., Orlov O.A. Al’fa-fetoprotein. — Ekaterinburg: UrO RAN, 2004. — 376 s.
- Bennett J.A., Zhu S., Pagano-Mirarchi A., Kellom T.A., Jacobson H.I. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin. Cancer Res. 1998; 4(11): 2877–2884.
- Parikh R.R., Gildener-Leapman N., Narendran A. et al. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alphafetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP. Clin. Cancer Res. 2005; 11(23): 8512–8520.
- Suzuki Y., Zeng C.Q., Alpert E. Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J. Clin. Invest. 1992; 90(4): 1530–1536.
- Torres J.M., Laborda J., Naval J. et al. Expression of alpha-fetoprotein receptors by human T-lymphocytes expressduring blastic transformation. Molec. Immunol. 1989; 57(2): 222–228.
- Moro R., Tamaoki Т., Wegmann T.G. et al. Monoclonal antibodies directed against a widespread oncofetal antigen: The Alpha-Fetoprotein Receptor.Tumor Biol. 1993; 14: 116–130.
- Nitsvetov M.B., Moskaleva E.Yu., Posypanova G.A. i dr. Izuchenie ekspressii retseptora AFP v opukholevykh i normal’nykh tkanyakh cheloveka s pomoshch’yu immunogistokhimicheskogo metoda. Immunologiya. 2004; 26(2): 122–125.
- Uriel J., Villacampa М.J., Моrо R. et al. Uptake of radio labeled AFP by mouse mammary carcinomas and its usefulness in tumor scintigraphy. Cancer Res. 1984; 44: 5314–5319.
- Severin S.E., Moskaleva E.Yu., Posypanova G.A. et al. In vivo antitumor activity of cytotoxic drugs conjugated with human α-fetoprotein. Tumor Targeting. 1996; 2: 299–306.
- Kulakov V.N., v sb. «Organicheskie soedineniya, mechennye radioaktivnymi izotopami». M., TsNIIAtominform, 1982. — Ch. 2. — 75–84 s.
- Mizejewski G.J., Butterstein G. .Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects. Curr. Protein Pept. Sci. 2006; 7: 73–100.
- Terentiev A.A., Moldogazieva N.T. Structural and functional mapping of alpha-fetoprotein. Biochemistry. 2006; 71: 120–132.